Pricing Log in Create free account
Friday 6 November 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

362.28 5.51 −1.50%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Labcorp Holdings Inc. (LH) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 4, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2026 P1I2: 7 added · 3 removed · 32 modified
P2I1A: no comparison — the earlier filing's Item cannot be compared
8-K Oct 28, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 20, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 30, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 22, 2026 7.01 Regulation FD disclosure
8-K Sep 10, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 28, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 17, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 11, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Jun 30, 2026 P1I2: 11 added · 1 removed · 34 modified
P2I1A: no material changes, the filing says
8-K Jul 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 8, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jun 30, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 27, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K May 21, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026 P1I2: 8 added · 21 removed · 53 modified
P2I1A: no material changes, the filing says
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 8, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 31, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 20, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 36 added · 164 removed · 52 modified
1A: 26 added · 59 removed · 57 modified
7: 9 added · 13 removed · 43 modified
8-K Feb 17, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 28, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Jan 15, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Jan 13, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Dec 30, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Dec 9, 2025 5.02 Departure or appointment of directors or officers
8-K Dec 5, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 20, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 5 added · 2 removed · 35 modified
P2I1A: no material changes, the filing says
8-K Oct 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 7, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 25, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Aug 27, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: no comparison — the earlier filing's text is no longer kept
P2I1A: no material changes, the filing says
8-K Jul 24, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K Apr 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 24, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 25, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 15, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.